The da Vinci Robot in the Field of Vascular Surgery  by Stadler, Petr et al.
JOURNAL OF VASCULAR SURGERY
584 Abstracts February 2015medical comorbidities, including ventilator dependence (2.1% vs 0.1%; P <
.01), congestive heart failure (8.7% vs 3.1%; P < .01), recent myocardial
infarction (4.5% vs 2%; P < .01), and insulin dependence (59.6% vs 53.6%;
P ¼ .03) compared with the NRA group. Preoperative vascular disease was
more severe in the RA group as well, with rest pain/gangrene (50.9% vs
39.1%; P < .01) and history of amputation (73.1% vs 49.8%; P < .01)
both higher in the RA group. The RA group also had a higher proportion
of emergency procedures (11.4% vs 4.4%; P < .01), longer operative time
(2266 11.5 minutes vs 208.46 2.6 minutes; P < .01) and longer prior hos-
pital length of stay (16.56 1.8 days vs 86 0.3 days; P < .01). The RA group
also was taken back to the operating room more frequently during the index
admission (36.2% vs 15.3%; P < .01) than the NRA group. Preoperative hy-
pertension (odds ratio, 46.7; 95% conﬁdence interval, 34.6-62.9) and rest
pain/gangrene (odds ratio, 50.1; 95% conﬁdence interval, 36.4-69.1) were
the only independent predictors of RA on multivariate analysis.
Conclusions: Insulin dependence and preoperative cardiac comorbid-
ities are not predictive of readmission rates after FPB in diabetic patients.
The presence of critical limb ischemia is the most predictive factor for 30-
day readmission after FPB in diabetic patients.
Author Disclosures: K. H. Nagarsheth: None; J. Schor: None; K.
Singh: None; M. D’Alessandro: None; S. Zia: None; J. Deitch: None.The da Vinci Robot in the Field of Vascular SurgeryTable I. Demographic, characteristics, and outcomes of patients with











Age, years 73.8 6 8.4 77.9 6 8.4 73.6 6 8.5 <.001
Female gender 20.4 33.8 20.0 .004Petr Stadler, MD, PhD, Libor Dvoracek, MD, Petr Vitasek, MD,
Pavel Matous, MD. Na Homolce Hospital, Praha 5, Czech Republic
Objectives: The da Vinci system has been used by a variety of disciplines
for laparoscopic procedures, but the use of robots in vascular surgery is still rela-
tively unknown. The feasibility of laparoscopic aortic surgery with robotic assis-
tance has been sufﬁciently demonstrated. Our clinical experience with robot-
assisted vascular surgery performed using the da Vinci system is described.
Methods: Between November 2005 and May 2014, we performed
310 robot-assisted vascular procedures. A total of 224 patients were pro-
spectively evaluated for occlusive diseases, 61 patients for abdominal aortic
aneurysm (Fig), 4 for a common iliac artery aneurysm, 4 for a splenic artery
aneurysm, 1 for an internal mammary artery aneurysm, 5 for hybrid proce-
dures, 2 for median arcuate ligament release, and 9 for type II endoleak
treatment after endovascular aneurysm repair.
Results: A total of 299 cases (96.5%) were successfully completed
robotically, and one patient’s (0.3%) surgery was discontinued during lapa-
roscopy due to heavy aortic calciﬁcation. Conversion was necessary in 10 pa-
tients (3.2%). The 30-day mortality rate was 0.3%, and early nonlethal
postoperative complications were observed in six patients (1.9%).
Conclusions: Our experience with robot-assisted laparoscopic sur-
gery has demonstrated the feasibility of this technique for occlusive diseases,
aneurysms, type II endoleak treatment after endovascular aneurysm repair,
for median arcuate ligament release, and hybrid procedures.Fig. The central anastomosis of the robotic abdominal aortic aneurysm
repair.
Maximum diameter 57.7 6 22.6 61.4 6 11.9 57.6 6 22.9 .14
Graft body diameter 27.2 6 3.9 28.8 6 3.9 27.2 6 3.6 <.001
Unplanned graft
extension
10.4 32.1 9.6 <.001
Hospital death 0.7 5.0 0.6 .002
Dysrhythmia 3.4 8.8 3.2 .018
Reoperation 2.0 5.0 1.9 .08
1-year mortality 5.7 8.8 5.6 .22
aData are shown as mean 6 standard deviation or as percentage.Author Disclosures: P. Stadler: None; L. Dvoracek: None; P. Vitasek:
None; P. Matous: None.Type I Endoleak at Completion of Endovascular
Abdominal Aneurysm Repair Is Associated With
Increased Perioperative Mortality
Tze-Woei Tan, MD1, Mohammad Eslami, MD2, Wayne W. Zhang, MD1,
Denis Rybin2, Doros Gheorghe2, Alik Farber, MD2. 1Louisiana State
University Health Sciences Center Shreveport, Shreveport, La; 2Boston
University Medical Center, Boston, Mass
Objectives: Type I endoleak (TIE) during endovascular abdominal
aortic aneurysm repair (EVAR) is usually identiﬁed and treated intraopera-
tively. We evaluated the outcomes of patients who, despite possible treat-
ment, had TIE at completion of EVAR.
Methods: We examined consecutive EVAR within the Vascular Study
Group of New England database (2003-2012), and the outcomes of patients
who had TIE at completion were compared with those who did not.
Ruptured abdominal aortic aneurysms were excluded. Outcomes included
perioperative death, cardiac complication, reoperation, and 1-year mortality.
Multivariable logistic regression was used to determine factors associated
with perioperative mortality as well as factors associated with TIE.
Results: Among the 2402 EVARs in the study cohort, 2235 (93%)
were performed electively; 167 (7%) had a symptomatic abdominal aortic
aneurysm. A TIE was present in 80 patients (3.3%) at completion of surgery;
these patients were older, more likely to be female, have a larger endograft
main body diameter, and have unplanned graft extension (Table). TIE was
associated with increased postoperative mortality (5% vs 0.6%; P ¼ .002)
and cardiac dysrhythmia (8.8% vs 3.2%; P ¼ .02). Four patients underwent
intraoperative conversion to open repair and none died before hospital
discharge. In multivariable analysis, TIE was associated with increased peri-
operative mortality (odds ratio [OR], 4.6; 95% conﬁdence interval [CI],
1.3-16.7; P ¼ .02). Other factors associated with perioperative death
included female gender (OR, 4.6; 95% CI, 1.7-12.8; P ¼ .003) and cardiac
dysrhythmia (OR, 17.5; 95% CI, 6.0-50.6); p30mm (OR, 2.5; 95% CI, 1.6-
4.4; P < .001) and unplanned graft extension (OR, 4.2; 95% CI, 2.5-7.3;
P < .001).
Conclusions: TIE at EVAR completion occurs in up to 3% of patients
and is associated with increasing age, female gender, larger endograft diam-
eter, and unplanned graft extension. TIE is associated with increased risk of
perioperative mortality. Additional study is needed to further deﬁne and
improve perioperative outcomes of these at-risk patients.Author Disclosures: T. Tan: None; M. Eslami: None; W. W. Zhang:
None; D. Rybin: None; D. Gheorghe: None; A. Farber: None.Patients With Familial Abdominal Aortic Aneurysms Are at
Increased Risk for Type 1 Endoleak Following Elective
Endovascular Aneurysm Repair
Biju K. Thomas, MD, Evan J. Ryer, MD, Robert P. Garvin, MD, Helena
Kuivaniemi, MD, Ph.D., David P. Franklin, MD, James R. Elmore, MD.
Geisinger Medical Center, Danville, Pa
Objectives: A recent investigation has documented increased aneu-
rysm-related complications after endovascular abdominal aortic aneurysm
(AAA) repair (EVAR) of familial AAAs (fAAAs). We hypothesized that
fAAA patients are not at increased risk after EVAR compared with EVAR
for sporadic AAAs (spAAA). To this end, we performed a retrospective re-
view of our single institution series.
Methods: Epidemiologic data was collected through the electronic
medical record. Major adverse events were deﬁned as myocardial infarction,
cardiac arrest, respiratory failure requiring tracheostomy, renal failure
